Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of Phycocyanobilin on experimental arthritis involve the reduction in nociception and synovial neutrophil infiltration, inhibition of cytokine production, and modulation of the neuronal proteome.
Marín-Prida J, Rodríguez-Ulloa A, Besada V, Llopiz-Arzuaga A, Batista NV, Hernández-González I, Pavón-Fuentes N, Marciano Vieira ÉL, Falcón-Cama V, Acosta EF, Martínez-Donato G, Cervantes-Llanos M, Lingfeng D, González LJ, Fernández-Massó JR, Guillén-Nieto G, Pentón-Arias E, Amaral FA, Teixeira MM, Pentón-Rol G. Marín-Prida J, et al. Among authors: rodriguez ulloa a. Front Immunol. 2023 Oct 23;14:1227268. doi: 10.3389/fimmu.2023.1227268. eCollection 2023. Front Immunol. 2023. PMID: 37936684 Free PMC article.
Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.
Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, Mendoza-Marí Y, Rodríguez-Ulloa A, García-Ojalvo A, Falcón-Cama V, Hernández-Bernal F, Beichen Q, Guillén-Nieto G. Berlanga-Acosta J, et al. Among authors: rodriguez ulloa a. Clin Med Insights Cardiol. 2017 Mar 2;11:1179546817694558. doi: 10.1177/1179546817694558. eCollection 2017. Clin Med Insights Cardiol. 2017. PMID: 28469491 Free PMC article. Review.
CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model.
Pérez GV, Rosales M, Ramón AC, Rodríguez-Ulloa A, Besada V, González LJ, Aguilar D, Vázquez-Blomquist D, Falcón V, Caballero E, Carvalho PC, Caldeira RS, Yang K, Perera Y, Perea SE. Pérez GV, et al. Among authors: rodriguez ulloa a. Biomedicines. 2022 Dec 25;11(1):43. doi: 10.3390/biomedicines11010043. Biomedicines. 2022. PMID: 36672551 Free PMC article.
Proteomic Study to Survey the CIGB-552 Antitumor Effect.
Rodríguez-Ulloa A, Gil J, Ramos Y, Hernández-Álvarez L, Flores L, Oliva B, García D, Sánchez-Puente A, Musacchio-Lasa A, Fernández-de-Cossio J, Padrón G, González López LJ, Besada V, Guerra-Vallespí M. Rodríguez-Ulloa A, et al. Biomed Res Int. 2015;2015:124082. doi: 10.1155/2015/124082. Epub 2015 Oct 20. Biomed Res Int. 2015. PMID: 26576414 Free PMC article.
Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells.
Rodríguez-Ulloa A, Ramos Y, Gil J, Perera Y, Castellanos-Serra L, García Y, Betancourt L, Besada V, González LJ, Fernández-de-Cossio J, Sanchez A, Serrano JM, Farina H, Alonso DF, Acevedo BE, Padrón G, Musacchio A, Perea SE. Rodríguez-Ulloa A, et al. J Proteome Res. 2010 Oct 1;9(10):5473-83. doi: 10.1021/pr100728v. J Proteome Res. 2010. PMID: 20804217
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300.
Rosales M, Pérez GV, Ramón AC, Cruz Y, Rodríguez-Ulloa A, Besada V, Ramos Y, Vázquez-Blomquist D, Caballero E, Aguilar D, González LJ, Zettl K, Wiśniewski JR, Yang K, Perera Y, Perea SE. Rosales M, et al. Among authors: rodriguez ulloa a. Biomedicines. 2021 Jul 1;9(7):766. doi: 10.3390/biomedicines9070766. Biomedicines. 2021. PMID: 34356831 Free PMC article.
17 results